The external FDA advisory panel assembled by HHS in July 2026 included doctors, pharmacists, and consultants working in the peptide industry

From the articleTrump administration advances plan for peptide drugs favored by RFK Jr.Also in Trump Administration Advances Plan for Peptides Favored by RFK Jr.